Myofibroblast Ccn3 is regulated by Yap and Wwtr1 and contributes to adverse cardiac outcomes is a research paper published in Frontiers in Cardiovascular Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 HL141159, R01 HL155085, T32 HL134643, F32 HL150958, F31 HL150919
National Institutes of Health
Grant: 1T32HL134643-01
Training in Signature Transdisciplinary Cardiovascular Sciences
National Institutes of Health
Grant: 3R01HL141159-05S1
IL13 - A Novel Therapeutic Factor for Cardiac Regeneration
National Institutes of Health
Grant: 3F32HL150958-01A1S1
The fibrogenic role of Hippo-Yap signaling following ischemic injury
National Institutes of Health
Grant: 1F31HL150919-01
Promoting Cardiomyocyte Cell Cycle Activity and Cardiac Regeneration through IL13 Signaling
National Institutes of Health
Grant: 5R01HL155085-04
Genetic interactions and multifactorial genetics mediate myocardial regeneration
Fields of Study
Keywords